Jackie Heda

Mechanism 1 Anifrolumab binds IFNAR1  

Prev Next
Previous

Multiple Myeloma

medical illustration of Mechanism 1: Anifrolumab, a monoclonal antibody, binds IFNAR1 and blocks the type I IFN from binding IFNAR1 preventing the formation of a functional IFNAR1/2 signaling complex.
Next medical illustration of Mode of action illustration showing the molecular factors leading to chronic psoriasis.

Mechanism 1: Anifrolumab, a monoclonal antibody, binds IFNAR1 and blocks the type I IFN from binding IFNAR1 preventing the formation of a functional IFNAR1/2 signaling complex.

Keywords: Color, Advertising / Marketing, Education, Allergy / Immunology, Disease Management, Mechanism of Action (MOA)

© Jackie Heda